{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:54:26Z","timestamp":1762649666045,"version":"build-2065373602"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,8]]},"DOI":"10.7759\/cureus.96388","type":"journal-article","created":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:49:47Z","timestamp":1762649387000},"source":"Crossref","is-referenced-by-count":0,"title":["Tatton-Brown-Rahman Syndrome Due to a Novel DNMT3A Variant Presenting With Autism, Attention-Deficit\/Hyperactivity Disorder (ADHD), and Regression: A Saudi Case Report"],"prefix":"10.7759","author":[{"given":"Abdulkarim O","family":"Alanazi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enas M","family":"Aljohani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sari","family":"Enani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-019-0485-3","article-title":"Further delineation of neuropsychiatric findings in Tatton-Brown-Rahman syndrome due to disease-causing variants in DNMT3A: seven new patients","volume":"28","author":"Tenorio J","year":"2020","unstructured":"Tenorio J, Alarc\u00f3n P, Arias P, et al.. Further delineation of neuropsychiatric findings in Tatton-Brown-Rahman syndrome due to disease-causing variants in DNMT3A: seven new patients. Eur J Hum Genet. 2020, 28:469-79. 10.1038\/s41431-019-0485-3","journal-title":"Eur J Hum Genet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.32641\/andespediatr.v93i4.4020","article-title":"Tatton-Brown-Rahman Syndrome: Case report and DNMT3A variant not previously reported associated to the syndrome","volume":"93","author":"Martin M F","year":"2022","unstructured":"Martin M F, D\u00edaz S C, Mira O M. Tatton-Brown-Rahman Syndrome: Case report and DNMT3A variant not previously reported associated to the syndrome. Andes Pediatr. 2022, 93:561-7. 10.32641\/andespediatr.v93i4.4020","journal-title":"Andes Pediatr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.14430.1","article-title":"The Tatton-Brown-Rahman Syndrome: a clinical study of 55 individuals with de novo constitutive DNMT3A variants","volume":"3","author":"Tatton-Brown K","year":"2018","unstructured":"Tatton-Brown K, Zachariou A, Loveday C, et al.. The Tatton-Brown-Rahman Syndrome: a clinical study of 55 individuals with de novo constitutive DNMT3A variants. Wellcome Open Res. 2018, 3:46. 10.12688\/wellcomeopenres.14430.1","journal-title":"Wellcome Open Res"},{"key":"ref4","article-title":"Tatton-Brown-Rahman syndrome","author":"Ostrowski PJ","year":"2022","unstructured":"Ostrowski PJ, Tatton-Brown K.. Tatton-Brown-Rahman syndrome. GeneReviews\u00ae. Adam MP, Feldman J, Mirzaa GM, et al. (ed): University of Washington, Seattle, WA; 2022."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.63434","article-title":"Tatton-Brown-Rahman syndrome: novel pathogenic variants and new neuroimaging findings","volume":"194","author":"Jim\u00e9nez de la Pe\u00f1a M","year":"2024","unstructured":"Jim\u00e9nez de la Pe\u00f1a M, Rinc\u00f3n-P\u00e9rez I, L\u00f3pez-Mart\u00edn S, et al.. Tatton-Brown-Rahman syndrome: novel pathogenic variants and new neuroimaging findings. Am J Med Genet A. 2024, 194:211-7. 10.1002\/ajmg.a.63434","journal-title":"Am J Med Genet A"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","article-title":"Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. American Psychiatric Publishing, Washington, DC; 2013. 10.1176\/appi.books.9780890425596"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.14426","article-title":"Tatton-Brown-Rahman syndrome: cognitive and behavioural phenotypes","volume":"62","author":"Lane C","year":"2020","unstructured":"Lane C, Tatton-Brown K, Freeth M. Tatton-Brown-Rahman syndrome: cognitive and behavioural phenotypes. Dev Med Child Neurol. 2020, 62:993-8. 10.1111\/dmcn.14426","journal-title":"Dev Med Child Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa013171","article-title":"Risperidone in children with autism and serious behavioral problems","volume":"347","author":"McCracken JT","year":"2002","unstructured":"McCracken JT, McGough J, Shah B, et al.. Risperidone in children with autism and serious behavioral problems. N Engl J Med. 2002, 347:314-21. 10.1056\/NEJMoa013171","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/CHI.0b013e3181b76658","article-title":"A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder","volume":"48","author":"Marcus RN","year":"2009","unstructured":"Marcus RN, Owen R, Kamen L, Manos G, McQuade RD, Carson WH, Aman MG. A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry. 2009, 48:1110-9. 10.1097\/CHI.0b013e3181b76658","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.768586","article-title":"Recognizing psychosis in autism spectrum disorder","volume":"13","author":"Ribolsi M","year":"2022","unstructured":"Ribolsi M, Fiori Nastro F, Pelle M, et al.. Recognizing psychosis in autism spectrum disorder. Front Psychiatry. 2022, 13:6. 10.3389\/fpsyt.2022.768586","journal-title":"Front Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/schizbullopen\/sgaa046","article-title":"The prevalence of psychotic experiences in autism spectrum disorder: a systematic review and meta-analysis","volume":"1","author":"Kiyono T","year":"2020","unstructured":"Kiyono T, Morimoto T, Sakusabe T, et al.. The prevalence of psychotic experiences in autism spectrum disorder: a systematic review and meta-analysis. Schizophr Bull Open. 2020, 1:46. 10.1093\/schizbullopen\/sgaa046","journal-title":"Schizophr Bull Open"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-021-05046-0","article-title":"Autism spectrum disorder and clinical high risk for psychosis: a systematic review and meta-analysis","volume":"52","author":"Vaquerizo-Serrano J","year":"2022","unstructured":"Vaquerizo-Serrano J, Salazar de Pablo G, Singh J, Santosh P. Autism spectrum disorder and clinical high risk for psychosis: a systematic review and meta-analysis. J Autism Dev Disord. 2022, 52:1568-86. 10.1007\/s10803-021-05046-0","journal-title":"J Autism Dev Disord"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.6065\/apem.2019.24.4.253","article-title":"First identified Korean family with Tatton-Brown-Rahman Syndrome caused by the novel DNMT3A variant c.118G>C p.(Glu40Gln)","volume":"24","author":"Lee CG","year":"2019","unstructured":"Lee CG, Jang JH, Seo JY. First identified Korean family with Tatton-Brown-Rahman Syndrome caused by the novel DNMT3A variant c.118G>C p.(Glu40Gln). Ann Pediatr Endocrinol Metab. 2019, 24:253-6. 10.6065\/apem.2019.24.4.253","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41439-020-0102-6","article-title":"Tatton-Brown-Rahman syndrome with a novel DNMT3A mutation presented severe intellectual disability and autism spectrum disorder","volume":"7","author":"Yokoi T","year":"2020","unstructured":"Yokoi T, Enomoto Y, Naruto T, Kurosawa K, Higurashi N. Tatton-Brown-Rahman syndrome with a novel DNMT3A mutation presented severe intellectual disability and autism spectrum disorder. Hum Genome Var. 2020, 7:15. 10.1038\/s41439-020-0102-6","journal-title":"Hum Genome Var"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/425408-tatton-brown-rahman-syndrome-due-to-a-novel-dnmt3a-variant-presenting-with-autism-attention-deficithyperactivity-disorder-adhd-and-regression-a-saudi-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:49:48Z","timestamp":1762649388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/425408-tatton-brown-rahman-syndrome-due-to-a-novel-dnmt3a-variant-presenting-with-autism-attention-deficithyperactivity-disorder-adhd-and-regression-a-saudi-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,8]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.96388","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,11,8]]}}}